- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Europe Small Molecule Drug Delivery Market: Industry Overview, Trends and Growth Opportunities Forecasted Till 2027
Aug 25, 2020
Infectious Disease Therapeutics Market is expected to reach US$ 1,67,883.93 million by 2030
Jan 25, 2024
Harvest Files Suit Against Falcon International, Inc.
Jan 07, 2020
Clinic Casting and Splinting Products Market is expected to reach US$ 2,085.57 million by 2030
Aug 02, 2023
North America In-Office Teeth Whitening Products Market is expected to reach US$ 5,818.23 million by 2028
Apr 21, 2023
The ITC Complaint Against Estar Medical in the U.S. Is Withdrawn by Regenlab
Mar 05, 2020
Patient-Derived Xenograft Model Market is expected to reach US$ 975.31 million by 2030
Feb 06, 2024
Follow us on
